JP2001187797A5 - - Google Patents

Download PDF

Info

Publication number
JP2001187797A5
JP2001187797A5 JP2000359948A JP2000359948A JP2001187797A5 JP 2001187797 A5 JP2001187797 A5 JP 2001187797A5 JP 2000359948 A JP2000359948 A JP 2000359948A JP 2000359948 A JP2000359948 A JP 2000359948A JP 2001187797 A5 JP2001187797 A5 JP 2001187797A5
Authority
JP
Japan
Prior art keywords
azithromycin
homoerythromycin
deoxo
aza
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000359948A
Other languages
English (en)
Japanese (ja)
Other versions
JP4260354B2 (ja
JP2001187797A (ja
Filing date
Publication date
Priority claimed from ES009902620A external-priority patent/ES2177373B1/es
Application filed filed Critical
Publication of JP2001187797A publication Critical patent/JP2001187797A/ja
Publication of JP2001187797A5 publication Critical patent/JP2001187797A5/ja
Application granted granted Critical
Publication of JP4260354B2 publication Critical patent/JP4260354B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000359948A 1999-11-26 2000-11-27 非結晶および結晶二水和物形態のアジスロマイシンの調製 Expired - Fee Related JP4260354B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902620A ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina
ES9902620 1999-11-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008217072A Division JP2009007376A (ja) 1999-11-26 2008-08-26 非結晶および結晶二水和物形態のアジスロマイシンの調製

Publications (3)

Publication Number Publication Date
JP2001187797A JP2001187797A (ja) 2001-07-10
JP2001187797A5 true JP2001187797A5 (https=) 2005-03-17
JP4260354B2 JP4260354B2 (ja) 2009-04-30

Family

ID=8310747

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000359948A Expired - Fee Related JP4260354B2 (ja) 1999-11-26 2000-11-27 非結晶および結晶二水和物形態のアジスロマイシンの調製
JP2008217072A Pending JP2009007376A (ja) 1999-11-26 2008-08-26 非結晶および結晶二水和物形態のアジスロマイシンの調製

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008217072A Pending JP2009007376A (ja) 1999-11-26 2008-08-26 非結晶および結晶二水和物形態のアジスロマイシンの調製

Country Status (9)

Country Link
US (1) US6451990B1 (https=)
EP (2) EP1103558B1 (https=)
JP (2) JP4260354B2 (https=)
AT (2) ATE325805T1 (https=)
CA (1) CA2326930C (https=)
DE (2) DE60003509T2 (https=)
ES (2) ES2177373B1 (https=)
PL (1) PL195910B1 (https=)
TR (1) TR200003474A3 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
HRP20030430B1 (hr) * 2000-11-27 2011-11-30 Biochemie S.A. Makrolidni solvati
IN190080B (https=) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
ES2258142T3 (es) 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
PL371259A1 (pl) 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
PL1558622T3 (pl) 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
CA2584430A1 (en) 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods for preparing pimecrolimus
JP2009501206A (ja) * 2005-07-14 2009-01-15 ファイザー・プロダクツ・インク 非晶質アジスロマイシン粒子の生成方法
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
CA2784494C (en) * 2009-12-18 2019-03-12 North-West University Composition comprising an amorphous non-crystalline glass form of roxithromycin
WO2013088274A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN106188177A (zh) * 2016-07-12 2016-12-07 浙江亚太药业股份有限公司 一种阿奇霉素化合物的制备方法及其药物制剂
CN108003109A (zh) * 2017-12-18 2018-05-08 南开大学 一种大环内酯化合物的晶型及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
US5686587A (en) 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
ECSP951389A (es) 1995-02-21 1996-05-10 Un procedimiento de obtencion de hidrato de azitromicina
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Similar Documents

Publication Publication Date Title
JP2001187797A5 (https=)
JP4225057B2 (ja) ナテグリニドb型結晶の製造方法
RU2577331C2 (ru) Кристаллическое основание миноциклина и способы его получения
JP5426693B2 (ja) アゴメラチンハロゲン化水素複合体及びその製造方法
JP2011519927A5 (https=)
FR2951171A1 (fr) Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
JP4518670B2 (ja) マクロライド製造の改善
WO2003050124A1 (en) Crystalline cefdinir potassium dihydrate
ES2320172T3 (es) Procedimiento para la produccion de 5-(4-(4-(5-ciano-3-indolil)-butil)-1-piperazinil)-benzofuran-2-carboxamida.
RU2006121341A (ru) Кристаллические формы дигидрохлорида (6r)-l-эритро-тетрагидробиоптерина
JP2004532319A5 (https=)
JP2005529082A5 (https=)
CN101952246A (zh) 制备3-(2,2,2-三甲基肼)丙酸盐二水合物的一锅法
MXPA04009009A (es) Pseudopolimorfos isoestructurales de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a.
KR101032600B1 (ko) 고순도 레바미피드의 제조방법
WO2010083722A1 (zh) 一锅煮方法合成corey内酯的工艺
US20090093420A1 (en) Processes for the preparation of azithromycin
CA2433067A1 (en) An improved method for preparation of cefuroxime axetil
TWI768595B (zh) 用於製備超純曲前列環素之高效結晶方法及由其製得之晶體
WO2006035291A1 (en) Crystalline forms of cefdinir potassium
CN101787026A (zh) 无定型的恩替卡韦甲苯磺酸盐,及其制备方法和药物应用
KR20100045986A (ko) 아데포비르 디피복실 결정형 일수화물 형태
KR20180105450A (ko) 피마살탄 콜린염 및 이의 수화물의 제조방법
CN104557865A (zh) 一种埃索美拉唑钠的制备方法
CN121914029A (zh) 一种阿福拉纳的β晶型及其制备方法与应用